Physician profile
Andrew Nelson
NPI 1861810541
$12,462.63
in general payments reported to CMS, 2019-2025
17 companies · $3,107 in 2025
The $3,107 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,494 · 2020: $1,977 · 2021: $355 · 2022: $439 · 2023: $861 · 2024: $4,231 · 2025: $3,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,198.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,604.53 | 2019-2025 | Mako, Tritanium, Insignia |
| Zimmer Biomet Holdings, INC. | $1,852.31 | 2019-2023 | G7, Gel-One Cross-Linked Hyaluronate |
| Maxx Orthopedics, INC. | $1,763.11 | 2023-2024 | |
| Medical Device Business Services, INC. | $344.97 | 2019 | |
| Davol INC. | $182.37 | 2024 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $155.46 | 2025 | Arista |
| Titan Surgical Group, LLC | $126.88 | 2023-2024 | |
| Medtronic USA, INC. | $93.69 | 2019 | |
| Depuy Synthes Sales INC. | $90.73 | 2022 | |
| Heron Therapeutics, INC. | $80.47 | 2024 | Zynrelef |
| Pacira Therapeutics, INC. | $44.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $39.21 | 2021-2025 | Iovera |
| Orthalign INC | $22.51 | 2024 | Orthalign Plus |
| Ethicon US, LLC | $17.18 | 2024 | Stratafix |
| Kowa Pharmaceuticals America, INC. | $15.20 | 2023 | Seglentis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.16 | 2025 | Xcell |
| Solventum Corporation | $13.93 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.